FYERS
Home
/
Stocks
/
Results
/
Supriya Lifescience Results

Supriya Lifescience Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
17%16%22%19%
43%11%33%11%
--46%39%
31%21%19%19%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
AUROPHARMA
LUPIN
DRREDDY
MANKIND
SUPRIYA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,861₹448316 Cr37.0612.0762.82₹11479 Cr
9,438.5₹251737 Cr86.0634.04128.41₹2568 Cr
4,930₹187594 Cr86.0116.7297.06₹2163 Cr
1,117.8₹112618 Cr24.959.4262.53₹5040 Cr
1,373.3₹110515 Cr32.799.7757.87₹3879 Cr
1,945₹104456 Cr95.546.829.25₹889 Cr
1,668.4₹97239 Cr26.1917.9596.84₹3505 Cr
2,077.8₹95660 Cr17.330.95154.36₹5333 Cr
1,143₹95421 Cr29.615.3263.99₹4196 Cr
2,238.4₹93596 Cr45.8213.7571.08₹1913 Cr
917.45₹7334 Cr36.972.9928.49₹209 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020
₹190 Cr₹277 Cr₹206 Cr₹200 Cr₹145 Cr₹184 Cr₹186 Cr₹166 Cr₹161 Cr₹158 Cr₹140 Cr₹140 Cr₹132 Cr₹142 Cr₹105 Cr₹112 Cr₹101 Cr₹181 Cr₹117 Cr₹148 Cr₹77 Cr₹132 Cr₹81 Cr
₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹5 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr
₹192 Cr₹280 Cr₹209 Cr₹203 Cr₹148 Cr₹187 Cr₹188 Cr₹169 Cr₹163 Cr₹160 Cr₹143 Cr₹143 Cr₹135 Cr₹144 Cr₹108 Cr₹115 Cr₹104 Cr₹185 Cr₹122 Cr₹151 Cr₹79 Cr₹134 Cr₹85 Cr
₹151 Cr₹187 Cr₹141 Cr₹134 Cr₹100 Cr₹123 Cr₹125 Cr₹106 Cr₹103 Cr₹107 Cr₹103 Cr₹112 Cr₹91 Cr₹90 Cr₹94 Cr₹87 Cr₹73 Cr₹109 Cr₹81 Cr₹57 Cr₹64 Cr₹67 Cr₹60 Cr
₹50 Cr₹101 Cr₹75 Cr₹75 Cr₹54 Cr₹71 Cr₹68 Cr₹67 Cr₹65 Cr₹58 Cr₹45 Cr₹34 Cr₹47 Cr₹57 Cr₹17 Cr₹31 Cr₹34 Cr₹79 Cr₹44 Cr₹97 Cr₹17 Cr₹69 Cr₹30 Cr
₹37 L₹47 L₹49 L₹42 L₹51 L₹42 L₹51 L₹43 L₹34 L₹60 L₹49 L₹46 L₹82 L₹71 L₹1 Cr₹78 L₹58 L₹1 Cr₹1 Cr₹17 Cr₹97 L₹1 Cr₹81 L
₹41 Cr₹92 Cr₹67 Cr₹68 Cr₹47 Cr₹64 Cr₹63 Cr₹62 Cr₹60 Cr₹53 Cr₹40 Cr₹30 Cr₹43 Cr₹53 Cr₹13 Cr₹27 Cr₹30 Cr₹75 Cr₹40 Cr₹78 Cr₹14 Cr₹66 Cr₹25 Cr
₹24 Cr₹74 Cr₹50 Cr₹50 Cr₹35 Cr₹50 Cr₹47 Cr₹46 Cr₹45 Cr₹37 Cr₹30 Cr₹24 Cr₹29 Cr₹38 Cr₹10 Cr₹17 Cr₹25 Cr₹46 Cr₹40 Cr₹58 Cr₹8 Cr₹49 Cr₹16 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009
——————————————————
₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹25 L₹25 L₹5 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹1 Cr₹0₹0₹77 L₹77 L₹2 Cr₹3 Cr₹0
₹1182 Cr₹981 Cr₹799 Cr₹683 Cr₹600 Cr₹254 Cr₹135 Cr₹79 Cr₹40 Cr₹31 Cr₹26 Cr₹33 Cr₹26 Cr₹20 Cr₹18 Cr₹16 Cr₹5 Cr₹90 L
₹1182 Cr₹981 Cr₹799 Cr₹683 Cr₹600 Cr₹254 Cr₹135 Cr₹79 Cr₹40 Cr₹26 Cr₹20 Cr₹26 Cr₹19 Cr₹13 Cr₹11 Cr₹9 Cr₹5 Cr₹90 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹7 Cr₹7 Cr₹7 Cr₹0₹0
₹1198 Cr₹997 Cr₹815 Cr₹699 Cr₹616 Cr₹269 Cr₹149 Cr₹94 Cr₹55 Cr₹46 Cr₹42 Cr₹37 Cr₹30 Cr₹26 Cr₹22 Cr₹19 Cr₹9 Cr₹95 L
₹0₹0₹0₹0₹0₹0₹2 Cr₹8 Cr₹35 Cr₹44 Cr₹31 Cr₹17 Cr₹13 Cr₹8 Cr₹6 Cr₹21 Cr₹20 Cr₹23 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 Cr₹4 Cr₹3 Cr₹87 L-₹21 L₹1 Cr₹1 Cr₹81 L₹7 Cr
₹31 Cr₹27 Cr₹23 Cr₹14 Cr₹11 Cr₹8 Cr₹8 Cr₹10 Cr₹9 Cr₹6 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹58 L
₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹22 Cr₹21 Cr₹6 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹2 Cr₹1 Cr₹80 L₹6 Cr₹3 Cr₹1 Cr₹1 Cr₹69 L₹58 L₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹38 Cr₹33 Cr₹29 Cr₹25 Cr₹19 Cr₹31 Cr₹32 Cr₹24 Cr₹45 Cr₹51 Cr₹39 Cr₹23 Cr₹17 Cr₹11 Cr₹9 Cr₹24 Cr₹22 Cr₹30 Cr
——————————————————
₹111 Cr₹75 Cr₹60 Cr₹64 Cr₹49 Cr₹51 Cr₹49 Cr₹44 Cr₹42 Cr₹41 Cr₹50 Cr₹30 Cr₹31 Cr₹24 Cr₹21 Cr₹17 Cr₹13 Cr₹11 Cr
₹9 Cr₹11 Cr₹20 Cr₹10 Cr₹23 Cr₹11 Cr₹26 Cr₹8 Cr₹15 Cr₹6 Cr₹4 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹56 L
₹0₹0₹0₹17 Cr₹21 Cr₹67 Cr₹77 Cr₹77 Cr₹86 Cr₹95 Cr₹95 Cr₹79 Cr₹47 Cr₹37 Cr₹26 Cr₹0₹0₹0
₹2 Cr₹1 Cr₹37 L₹5 Cr₹7 Cr₹16 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹77 L₹1 Cr
₹121 Cr₹87 Cr₹80 Cr₹96 Cr₹100 Cr₹146 Cr₹155 Cr₹135 Cr₹146 Cr₹144 Cr₹150 Cr₹115 Cr₹83 Cr₹65 Cr₹50 Cr₹20 Cr₹15 Cr₹13 Cr
₹1357 Cr₹1117 Cr₹924 Cr₹820 Cr₹735 Cr₹445 Cr₹336 Cr₹253 Cr₹245 Cr₹241 Cr₹231 Cr₹176 Cr₹130 Cr₹101 Cr₹82 Cr₹63 Cr₹46 Cr₹44 Cr
₹9 Cr₹4 Cr₹3 Cr₹6 Cr₹6 Cr₹2 Cr₹92 L₹54 L₹54 L₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹17 Cr₹21 Cr₹70 Cr₹82 Cr₹90 Cr₹130 Cr₹140 Cr₹129 Cr₹99 Cr₹62 Cr₹45 Cr₹33 Cr₹23 Cr₹21 Cr₹30 Cr
——————————————————
₹799 Cr₹534 Cr₹371 Cr₹306 Cr₹223 Cr₹123 Cr₹114 Cr₹95 Cr₹96 Cr₹98 Cr₹89 Cr₹71 Cr₹53 Cr₹44 Cr₹36 Cr₹32 Cr₹21 Cr₹19 Cr
₹110 Cr₹81 Cr₹61 Cr₹45 Cr₹33 Cr₹23 Cr₹16 Cr₹10 Cr₹5 Cr₹9 Cr₹14 Cr₹10 Cr₹7 Cr₹5 Cr₹4 Cr₹3 Cr₹1 Cr₹65 L
₹689 Cr₹453 Cr₹310 Cr₹262 Cr₹190 Cr₹100 Cr₹98 Cr₹85 Cr₹91 Cr₹89 Cr₹75 Cr₹61 Cr₹45 Cr₹39 Cr₹32 Cr₹29 Cr₹20 Cr₹18 Cr
₹36 Cr₹148 Cr₹149 Cr₹68 Cr₹43 Cr₹79 Cr₹40 Cr₹35 Cr₹34 Cr₹36 Cr₹25 Cr₹11 Cr₹5 Cr₹32 L₹39 L₹42 L₹98 L₹1 Cr
₹99 Cr₹63 Cr₹64 Cr₹25 Cr₹5 L₹5 L₹5 L₹5 L₹12 L₹10 L₹10 L₹10 L₹9 L₹3 L₹2 L₹1 L₹25,000₹25,000
₹99 Cr₹63 Cr₹64 Cr₹25 Cr₹5 L₹5 L₹5 L₹5 L₹12 L₹10 L₹10 L₹10 L₹9 L₹3 L₹2 L₹1 L₹25,000₹25,000
₹2 Cr₹11 Cr₹68 L₹93 L₹4 Cr₹1 Cr₹18 L₹30 L₹32 L₹2 Cr₹2 Cr₹33 L₹1 Cr₹37 L₹33 L₹0₹0₹0
₹825 Cr₹675 Cr₹523 Cr₹355 Cr₹237 Cr₹180 Cr₹138 Cr₹120 Cr₹126 Cr₹126 Cr₹102 Cr₹73 Cr₹52 Cr₹39 Cr₹33 Cr₹30 Cr₹21 Cr₹19 Cr
——————————————————
₹160 Cr₹118 Cr₹85 Cr₹116 Cr₹92 Cr₹72 Cr₹49 Cr₹31 Cr₹32 Cr₹38 Cr₹53 Cr₹39 Cr₹30 Cr₹30 Cr₹24 Cr₹15 Cr₹9 Cr₹7 Cr
₹219 Cr₹134 Cr₹112 Cr₹85 Cr₹115 Cr₹74 Cr₹52 Cr₹60 Cr₹53 Cr₹50 Cr₹42 Cr₹35 Cr₹28 Cr₹18 Cr₹16 Cr₹12 Cr₹8 Cr₹10 Cr
₹79 Cr₹79 Cr₹75 Cr₹158 Cr₹228 Cr₹89 Cr₹2 Cr₹2 Cr₹3 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹93 L
₹9 Cr₹11 Cr₹16 Cr₹17 Cr₹13 Cr₹4 Cr₹1 Cr₹32 L₹63 L₹1 Cr₹64 L₹1 Cr₹56 L₹66 L₹17 L₹41 L₹19 L₹12 L
₹65 Cr₹99 Cr₹113 Cr₹90 Cr₹49 Cr₹26 Cr₹93 Cr₹40 Cr₹31 Cr₹20 Cr₹26 Cr₹23 Cr₹16 Cr₹10 Cr₹6 Cr₹5 Cr₹6 Cr₹7 Cr
₹532 Cr₹442 Cr₹400 Cr₹465 Cr₹498 Cr₹265 Cr₹198 Cr₹133 Cr₹120 Cr₹115 Cr₹129 Cr₹103 Cr₹78 Cr₹62 Cr₹49 Cr₹33 Cr₹25 Cr₹25 Cr
₹411 Cr₹355 Cr₹321 Cr₹369 Cr₹398 Cr₹119 Cr₹43 Cr-₹2 Cr-₹26 Cr-₹29 Cr-₹21 Cr-₹12 Cr-₹4 Cr-₹3 Cr-₹1 Cr₹13 Cr₹10 Cr₹12 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 L₹3 L₹4 L
₹1357 Cr₹1117 Cr₹924 Cr₹820 Cr₹735 Cr₹445 Cr₹336 Cr₹253 Cr₹245 Cr₹241 Cr₹231 Cr₹176 Cr₹130 Cr₹101 Cr₹82 Cr₹63 Cr₹46 Cr₹44 Cr
₹149₹124₹101₹87₹76₹37₹102₹64₹37₹28₹24₹64₹49₹38₹43₹378₹221₹182
₹149₹124₹101₹87₹76₹37₹20₹13₹7₹6₹5₹4₹3₹2₹0₹1₹1₹1

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009
₹275 Cr₹248 Cr₹166 Cr₹123 Cr₹207 Cr₹167 Cr₹96 Cr₹57 Cr₹14 Cr₹8 Cr₹8 Cr₹10 Cr₹9 Cr₹0₹0₹0₹0₹0
₹20 Cr₹14 Cr₹2 Cr₹5 Cr₹7 Cr₹5 Cr₹10 Cr₹13 Cr₹16 Cr₹16 Cr₹13 Cr₹9 Cr₹8 Cr₹0₹0₹0₹0₹0
-₹47 Cr-₹38 Cr-₹17 Cr-₹34 Cr-₹104 Cr-₹67 Cr₹37 Cr-₹7 Cr₹80 L₹3 Cr-₹7 Cr-₹25 Cr-₹10 Cr₹0₹0₹0₹0₹0
₹247 Cr₹224 Cr₹151 Cr₹94 Cr₹110 Cr₹106 Cr₹143 Cr₹63 Cr₹31 Cr₹27 Cr₹15 Cr-₹6 Cr₹6 Cr₹0₹0₹0₹0₹0
₹186 Cr₹165 Cr₹113 Cr₹64 Cr₹49 Cr₹76 Cr₹116 Cr₹49 Cr₹28 Cr₹27 Cr₹14 Cr-₹6 Cr₹5 Cr₹0₹0₹0₹0₹0
-₹176 Cr-₹152 Cr-₹174 Cr-₹124 Cr-₹60 Cr-₹47 Cr-₹25 Cr₹5 Cr-₹5 Cr-₹27 Cr-₹33 Cr-₹23 Cr-₹14 Cr₹0₹0₹0₹0₹0
-₹10 Cr-₹8 Cr-₹22 Cr-₹10 Cr₹150 Cr-₹15 Cr-₹29 Cr-₹50 Cr-₹20 Cr-₹2 Cr₹21 Cr₹30 Cr₹10 Cr₹0₹0₹0₹0₹0
-₹29 L₹4 Cr-₹83 Cr-₹70 Cr₹139 Cr₹15 Cr₹62 Cr₹4 Cr₹3 Cr-₹2 Cr₹2 Cr₹75 L₹1 Cr₹0₹0₹0₹0₹0
₹79 Cr₹75 Cr₹158 Cr₹228 Cr₹89 Cr₹75 Cr₹12 Cr₹9 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr₹3 Cr₹0₹0₹0₹0₹0
₹79 Cr₹79 Cr₹75 Cr₹158 Cr₹228 Cr₹89 Cr₹75 Cr₹12 Cr₹9 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr₹0₹0₹0₹0₹0

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)912.00
Volume (₹)2.44 L
High (₹)933.15
Upper Circuit1,093.65
Low (₹)902.80
Lower Circuit729.15
Prev Close911.40
52W High (₹)1,085.00
Price917.45
52W Low (₹)545.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)7394.36 Cr
Div. Yield (%)0.11
PE Ratio37.27
Debt to Equity0.00
Price to Book3.80
Book Value148.81
EPS (TTM)24.65
Face Value2.00
ROE (%)19.06

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
SUPRIYANSE
LTP
1W Low
1W High
Market cap (₹)
1861+0 (0.00%)
1840.50
1907.80
4,48,316Cr
9438.5+0 (0.00%)
9119.50
9615
2,51,737Cr
4930+0 (0.00%)
4823
5000
1,87,594Cr
1117.8+0 (0.00%)
1108.10
1167.70
1,12,618Cr
1373.3+0 (0.00%)
1363.10
1398.40
1,10,515Cr
1945+0 (0.00%)
1832.70
1955
1,04,456Cr
1668.4+0 (0.00%)
1646
1704
97,239Cr
2077.8+0 (0.00%)
2060.30
2135.50
95,660Cr
1143+0 (0.00%)
1134.90
1163.20
95,421Cr
2238.4+0 (0.00%)
2235.10
2331.60
93,596Cr
917.45+0 (0.00%)
864
933.15
7,334Cr

Supriya Lifescience Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Supriya Lifescience Ltd Quaterly Results Key Takeaways